Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer
NCT05002634 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2021-08-12
Summary
This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. Liver function test, renal function test, and adverse event will be assessed.
Conditions
- Health, Subjective
Interventions
- DIETARY_SUPPLEMENT
-
undenatured collagen type II (UCII) supplement
The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months.
Sponsors & Collaborators
-
Chulalongkorn University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-05
- Primary Completion
- 2022-06-30
- Completion
- 2022-07-31
More Related Trials
-
Adult Pilot Study for Reference Ranges and Optimal Cut-offs for the Sucrose Challenge Test and Sucrose Breath Test
NCT05045495 ·Status: COMPLETED
-
Application of n-3 Fatty to Patient of Jaundice
NCT03376945 ·Status: COMPLETED
-
Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression
NCT05291104 ·Status: COMPLETED ·Phase: NA
-
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917 ·Status: COMPLETED ·Phase: NA
-
Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLD
NCT05635474 ·Status: UNKNOWN ·Phase: NA
-
Prebiotics in Patients With Non-alcoholic Liver Disease
NCT02642172 ·Status: COMPLETED ·Phase: NA
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
NCT04147936 ·Status: COMPLETED ·Phase: NA
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Acetyl-L-carnitine on Chronic Pancreatitis
NCT02538146 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
NCT02381769 ·Status: COMPLETED ·Phase: NA
-
ButyraGen™, Short Chain Fatty Acids and Gut Microbiome
NCT05601635 ·Status: COMPLETED ·Phase: NA
-
To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
NCT02691533 ·Status: COMPLETED ·Phase: NA
-
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
NCT06425380 ·Status: RECRUITING ·Phase: NA
-
Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
NCT02830763 ·Status: TERMINATED ·Phase: NA
-
Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study
NCT02520817 ·Status: COMPLETED
-
Phase I Clinical Study of Chondroitin Sulfate for Treatment of NEC
NCT06547424 ·Status: WITHDRAWN ·Phase: PHASE1
-
Reactions to Contrast Media (CM) Administered at the Time of the Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT00900640 ·Status: COMPLETED
-
Citrulline Challenge Study for Healthy Subjects in the United Kingdom
NCT02772861 ·Status: COMPLETED ·Phase: NA
-
Zinc Supplementation in Alcoholic Cirrhosis
NCT02072746 ·Status: COMPLETED ·Phase: NA
-
Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis
NCT05043194 ·Status: UNKNOWN ·Phase: NA
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Alanine in Patients With Nonalcoholic Steatohepatitis
NCT00586885 ·Status: COMPLETED ·Phase: NA
-
Impact Of Choline in Patients With NAFLD
NCT05200156 ·Status: UNKNOWN ·Phase: NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
NCT03073343 ·Status: RECRUITING ·Phase: NA